|
1
|
Global Burden of Disease Cancer
Collaboration, ; Fitzmaurice C, Dicker D, Pain A, Hamavid H,
Moradi-Lakeh M, MacIntyre MF, Allen C, Hansen G, Woodbrook R, et
al: The global burden of cancer 2013. JAMA Oncol. 1:505–527. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
van Deudekom FJ, Klop HG, Hartgrink HH,
Boonstra JJ, Lips IM, Slingerland M and Mooijaart SP: Functional
and cognitive impairment, social functioning, frailty and adverse
health outcomes in older patients with esophageal cancer, a
systematic review. J Geriatr Oncol. 9:560–568. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sohda M and Kuwano H: Current status and
future prospects for esophageal cancer treatment. Ann Thorac
Cardiovasc Surg. 23:1–11. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yang H, Liu H, Chen Y, Zhu C, Fang W, Yu
Z, Mao W, Xiang J, Han Y, Chen Z, et al: Neoadjuvant
chemoradiotherapy followed by surgery versus surgery alone for
locally advanced squamous cell carcinoma of the esophagus
(NEOCRTEC5010): A phase III multicenter, randomized, open-label
clinical trial. J Clin Oncol. 36:2796–2803. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Shapiro J, van Lanschot JJB, Hulshof MCCM,
van Hagen P, van Berge Henegouwen MI, Wijnhoven BPL, van Laarhoven
HWM, Nieuwenhuijzen GAP, Hospers GAP, Bonenkamp JJ, et al:
Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for
oesophageal or junctional cancer (CROSS): Long-term results of a
randomised controlled trial. Lancet Oncol. 16:1090–1098. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tapias LF, Muniappan A, Wright CD,
Gaissert HA, Wain JC, Morse CR, Donahue DM, Mathisen DJ and Lanuti
M: Short and long-term outcomes after esophagectomy for cancer in
elderly patients. Ann Thorac Surg. 95:1741–1748. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Xu C, Xi M, Moreno A, Shiraishi Y, Hobbs
BP, Huang M, Komaki R and Lin SH: Definitive chemoradiation therapy
for esophageal cancer in the elderly: Clinical outcomes for
patients exceeding 80 years old. Int J Radiat Oncol Biol Phys.
98:811–819. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Markar SR, Karthikesalingam A, Thrumurthy
S, Ho A, Muallem G and Low DE: Systematic review and pooled
analysis assessing the association between elderly age and outcome
following surgical resection of esophageal malignancy. Dis
Esophagus. 26:250–262. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Steyerberg EW, Neville B, Weeks JC and
Earle CC: Referral patterns, treatment choices, and outcomes in
locoregional esophageal cancer: A population-based analysis of
elderly patients. J Clin Oncol. 25:2389–2396. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Miyata H, Yamasaki M, Makino T, Miyazaki
Y, Takahashi T, Kurokawa Y, Nakajima K, Takiguchi S, Mori M and
Doki Y: Clinical outcome of esophagectomy in elderly patients with
and without neoadjuvant therapy for thoracic esophageal cancer. Ann
Surg Oncol. 22 (Suppl 3):S794–S801. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Morita M, Otsu H, Kawano H, Kumashiro R,
Taketani K, Kimura Y, Saeki H, Ando K, Ida S, Oki E, et al:
Advances in esophageal surgery in elderly patients with thoracic
esophageal cancer. Anticancer Res. 33:1641–1647. 2013.PubMed/NCBI
|
|
12
|
Hamamoto Y, Akutsu Y, Nagashima F,
Hironaka S, Ito Y, Kato K, Hara H, Tsubosa Y, Nakagawa S, Daiko H,
et al: Multicenter questionnaire survey on patterns of care for
elderly patients with esophageal squamous cell carcinoma by the
Japan Esophageal Oncology Group. Jpn J Clin Oncol. 46:111–115.
2016.PubMed/NCBI
|
|
13
|
Talsma K, van Hagen P, Grotenhuis BA,
Steyerberg EW, Tilanus HW, van Lanschot JJ and Wijnhoven BP:
Comparison of the 6th and 7th Editions of the UICC-AJCC TNM
Classification for Esophageal Cancer. Ann Surg Oncol. 19:2142–2148.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zeng Y, Liang W, Liu J, He J, Ng CSH, Liu
CC, Petersen RH, Rocco G, D'Amico T, Brunelli A, et al: Esophageal
cancer in elderly patients: A population-based study. J Thorac Dis.
10:448–457. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen MF, Yang YH, Lai CH, Chen PC and Chen
WC: Outcome of patients with esophageal cancer: A nationwide
analysis. Ann Surg Oncol. 20:3023–3030. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Oyama T: Esophageal ESD: Technique and
prevention of complications. Gastrointest Endosc Clin N Am.
24:201–212. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ikeda A, Hoshi N, Yoshizaki T, Fujishima
Y, Ishida T, Morita Y, Ejima Y, Toyonaga T, Kakechi Y, Yokosaki H
and Azuma T: Endoscopic submucosal dissection (ESD) with additional
therapy for superficial esophageal cancer with submucosal invasion.
Intern Med. 54:2803–2813. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kawaguchi G, Sasamoto R, Abe E, Ohta A,
Sato H, Tanaka K, Maruyama K, Kaizu M, Ayukawa F, Yamana N, et al:
The effectiveness of endoscopic submucosal dissection followed by
chemoradiotherapy for superficial esophageal cancer. Radiat Oncol.
10:312015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Morita M, Egashira A, Yoshida R, Ikeda K,
Ohgaki K, Shibahara K, Oki E, Sadanaga N, Kakeji Y and Maehara Y:
Esophagectomy in patients 80 years of age and older with carcinoma
of the thoracic esophagus. J Gastroenterol. 43:345–351. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tougeron D, Di Fiore F, Thureau S, Berbera
N, Iwanicki-Caron I, Hamidou H, Paillot B and Michel P: Safety and
outcome of definitive chemoradiotherapy in elderly patients with
oesophageal cancer. Br J Cancer. 99:1586–1592. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Janjigian YY, Bendell J, Calvo E, Kim JW,
Ascierto PA, Sharma P, Ott PA, Peltola K, Jaeger D, Evans J, et al:
CheckMate-032 study: Efficacy and safety of nivolumab and nivolumab
plus ipilimumab in patients with metastatic esophagogastric cancer.
J Clin Oncol. 36:2836–2844. 2018. View Article : Google Scholar : PubMed/NCBI
|
